Journal
JOURNAL OF PHARMACY AND PHARMACOLOGY
Volume 66, Issue 11, Pages 1552-1558Publisher
WILEY-BLACKWELL
DOI: 10.1111/jphp.12282
Keywords
antibiotics; bone surgery; ceftriaxone; HPLC; population pharmacokinetics
Categories
Ask authors/readers for more resources
ObjectivesPatients undergoing hip or knee replacement therapy are routinely pretreated with antibiotics before surgery. It is controversial in which antibiotic is the treatment of choice for this purpose. One possibility is the cephalosporin ceftriaxone. Here, we wanted to know if effective tissue concentrations are reached. MethodsWe studied plasma and bone kinetics of ceftriaxone in orthopaedic patients (n=22) treated with ceftriaxone (2g) immediately prior operation. Plasma samples were withdrawn before and at three time points after ceftriaxone infusion. After bone replacement, extracts from cancellous bone or cortical bone were obtained, and ceftriaxone was quantified using column chromatography. Key findingsThe plasma kinetics of ceftriaxone and distribution into bone were analysed using a population approach (ADAPT 5). The population mean of the area under the curve (AUC) was 140mg h/l. A cancellous bone to plasma concentration ratio of 1.121.29 was achieved 5h after start of infusion. The half-life of uptake into the cortical bone was less (8.4h) than into cancellous bone (12.1h, P<0.05). ConclusionsUnder these experimental conditions, concentrations of ceftriaxone in cancellous and cortical bone should be adequate to protect the patients against usual ceftriaxone-sensitive nosocomial infections and are substantially lower than the plasma concentrations.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available